Biocon Statements
BI
Biocon Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
78 708
100
25 613
33.9
53 095
66.1
—
0
14 624
18.9
42 883
53.1
10 212
13
-5 205
-5.9
5 834
1.2
11 272
8.1
1 510
2.5
7 955
3.5
6.64
1 198.47
68 849
100
23 366
32.6
45 483
67.4
—
0
12 017
18
38 396
57.3
7 087
10.2
-5 381
-7.9
2 514
4.6
3 980
6.2
764
1.2
2 270
3.6
1.9
1 194.57
67 150
100
22 084
32.6
45 066
67.4
—
0
11 281
15.1
35 298
50.7
9 768
16.8
-4 648
-7.7
2 335
4.1
4 711
13.2
773
2.2
2 714
8.3
2.269
1 194.85
44 592
100
14 547
32.4
30 045
67.6
—
0
10 529
23.3
25 827
57.2
4 218
10.3
-1 212
-2.5
1 424
2.8
4 260
9.9
1 768
6.3
1 913
2
1.6
1 198
45 830
100
15 412
34.4
30 418
65.6
—
0
9 653
19.5
23 796
49.9
6 622
15.8
-1 254
-2.6
1 156
2.8
6 114
14.2
1 079
2.4
4 257
9.9
3.55
1 200
36 010
100
11 772
30.7
24 238
69.3
—
0
9 148
26
19 850
56
4 388
13.3
-1 491
-4
1 521
5.7
3 717
11.2
1 036
2.5
2 227
7.5
1.87
1 190.5
37 270
100
11 707
31.4
25 563
68.6
—
0
9 154
24.5
20 844
54.9
4 719
13.6
-1 181
-5.6
2 263
11.2
5 927
19.9
1 183
3.8
4 218
13.7
3.54
1 189
34 161
100
10 730
29.6
23 431
70.4
—
0
8 256
25.1
18 773
57.6
4 658
12.7
-190
-0.2
282
0.6
4 750
13.1
1 032
1.3
3 187
9.8
2.63
1 207.5
32 743
100
10 979
35.3
21 764
64.7
—
0
7 645
24.9
17 100
54
4 664
10.7
-345
-1.08
989
4.1
5 308
13.6
1 298
2.9
3 262
7.9
2.73
1 186.5
30 262
100
8 916
30.2
21 346
69.8
—
0
6 943
22.5
15 501
52.5
5 845
17.3
-304
-0.9
625
2.5
6 841
23.2
1 853
6.4
4 220
13.8
3.55
1 185.5
30 696
100
10 160
31.9
20 536
68.1
—
0
6 150
21
15 016
49.6
5 520
18.5
-274
-1.8
490
1.8
5 736
18.6
870
2.7
4 309
14
3.65
1 181
24 448
100
8 806
33.8
15 642
66.2
—
0
5 503
21.9
11 703
46.9
3 939
19.3
1 520
12.8
954
2
6 413
34.1
1 253
5.5
4 744
26.9
3.94
1 199